Screen Candida Test is a rapid qualitative self-diagnosis test that can detect the presence of Candida antigens in vaginal secretion samples taken by swabbing. Result in 10 minutes. Screen Test Candida is an in vitro diagnostic Medical Device CE 0483. Carefully read the warnings and instructions for use
SCREEN ITALIA
Italy
The SARS-CoV-2 (COVID-19) Antigen Rapid Test (Saliva) is a single-use test intended to detect in human saliva the novel coronavirus SARS-CoV-2 that causes COVID-19. This test is designed for home use with saliva samples collected independently from symptomatic individuals suspected of being infected with SARS-CoV-2. With the rapid SARS-CoV-2 (COVID-19) antigen test (Saliva), only a preliminary result is obtained; final confirmation should be based on the results of clinical diagnosis. Result in 15 minutes. Screen Check Test Covid-19 Saliva is an in vitro diagnostic medical device CE 1434. Read the warnings and instructions for use carefully.
Request for a quoteSCREEN ITALIA
Italy
Rapid test for qualitative detection of protein nucleocapsid SARS-CoV-2 and nucleoprotein antigens of influenza A and influenza B present in the nasal swab sample. The Rapid COVID-19 and Influenza A + B Antigen Test (nasal swab) is a membrane-based qualitative immunoassay for the determination of SARS-CoV-2 and Influenza A + B antigens from a swab of human nasal sample. Result in 15 minutes. Screen Test Sars-Cov-2 + Influenza A + B is an in vitro diagnostic Medical Device CE 1434. Read the warnings and operating instructions carefully.
Request for a quoteSCREEN ITALIA
Italy
Screen Test Streptococcus A is a rapid test for self-diagnostic use for the qualitative detection of group A streptococcus antigen from pharyngeal swab specimens to aid in the early diagnosis of group A Streptococcus infection. Screen Check Test Streptococcus A is an in vitro diagnostic medical device CE 0123. Read the warnings and operating instructions carefully. Authorization of 7/04/2021. Benefits Streptococcus A detection Rapid result for streptococcal A antigen
Request for a quoteSCREEN ITALIA
Italy
The rapid Screen Test Igg Sars-Cov-2 S-RBD test from whole prick blood is a rapid immunochromatographic test for the qualitative detection of IgG antibodies to the receptor binding domain (RBD) spike (S) protein of SARS-CoV-2 in human whole prick blood at approximately 10 days after vaccination. Screen Test Covid-19 Igg Sars-Cov-2 S-RBD is an in vitro diagnostic medical device CE 1434. Read the warnings and operating instructions carefully.
Request for a quote